Institutional Ownership
Genocea Biosciences Inc Ordinary Shares
CUSIP 372427401COMGNCAQQ1 2026
13D / 13G Filings
11
Schedule 13D/13G on record
Beneficial Filers
5
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
11 filings · latest Feb 14, 2022
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 14, 2022 | Citadel Advisors LLC | 13G/A | 6.0% | — | SEC |
| 2 | Feb 14, 2022 | Biotechnology Value Fund L P | 13G/A | 5.8% | 3.43M | SEC |
| 3 | Feb 14, 2022 | Commodore Capital LP | 13G/A | 5.4% | 3.08M | SEC |
| 4 | Mar 31, 2021 | Commodore Capital LP | 13G | 5.4% | 2.87M | SEC |
| 5 | Feb 16, 2021 | Ubs Oconnor LLC | 13G/A | 3.3% | 1.77M | SEC |
| 6 | Feb 16, 2021 | Citadel Advisors LLC | 13G/A | 6.5% | — | SEC |
| 7 | Feb 12, 2021 | Biotechnology Value Fund L P | 13G/A | 5.3% | 2.79M | SEC |
| 8 | Feb 12, 2021 | Avoro Capital Advisors LLC | 13G | 10.0% | 33.61M | SEC |
| 9 | Jul 31, 2020 | Citadel Advisors LLC | 13G | 6.4% | — | SEC |
| 10 | Feb 14, 2020 | Biotechnology Value Fund L P | 13G/A | 3.2% | 1.53M | SEC |
1 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Genocea Biosciences Inc Ordinary Shares.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ascentis Independent Advisors | 3.0K | $0 |